Shots: Alligator reports that it has submitted a CTA application to the relevant regulatory authorities to start a P-II efficacy study of its CD40 targeting antibody mitazalimab Upcoming P-II OPTIMIZE-1 […]readmore
Tags : Alligator Bioscience
Shots: Alligator to receive ~52M in development milestones including $1M up front, $90M as option fee and royalties on sales and share of sub-license revenue. Biotheus to get right to […]readmore